Chitosan-based particles as controlled drug delivery systems

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 12, Issue 1, 2005, Pages 41-57

  Prabaharan, M ^a   Mano, J F ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

Chitosan; Drug Delivery; Microspheres; Polyanions; Self Assemblies

Indexed keywords

CHITOSAN;

CELL MEMBRANE; CHEMICAL ANALYSIS; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CROSS LINKING; DEACETYLATION; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; EPITHELIUM CELL; GENETIC TRANSFECTION; HYDROPHOBICITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW;

CHITOSAN; DNA; DRUG DELIVERY SYSTEMS; TRANSFECTION;

EID: 11244281032     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540590889781     Document Type: Review

References (125)

1. Akbuga, J., and Durmaz, G. 1994. Preparation and evaluation of cross-linked chitosan microspheres containing furosemide. Intl. J. Pharm. 111:217-222.
2. Alonso, M. J., Calvo, P., Remunan, C., and Jato, J. L. V. 1997. Stabilization of colloidal systems by the formation of ionic lipid-polysaccharide complexes. EP 0 771 566 A1
3. Alonso, M. J., Calvo, P., Remunan, C., and Jato, J. L. V. 1998. Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms. EP 0 860 166 A1.
4. Artursson, A., Lindmark, T., Davis, S. S., and Illurn, L. 1994. Effect of chitosan on the permeability of mono layers of intestinal epithelial cells (Caco-2). Pharm. Res. 11:1358-1361.
5. Bersch, P. C., Nies, B., and Liebendorfer, A. 1995. Evaluation of the biological properties of different wound dressing materials. J. Mater. Sci. Med. 6:231-240.
6. Berthold, A., Cremer, K., and Kreuter, J. 1996. Influence of cross-linking on the acid stability and physicochemical properties of chitosan microspheres. STP Pharm. Sci. 6:358-364.
7. Berthold, A., Cremer, K., and Kreuter, J. 1996a. Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Rel. 39:17-25.
8. Blanco, D., and Alonso, M. J. 1997. Development and characterization of protein-loaded poly (lactide-co-glycolide) nanospheres. Euro. J. Pharm. Biopharm. 43:287-294.
9. Bodmeier, R., Chen, H., and Paeratakul, O. 1989. A novel approach to the delivery of microparticles or nanoparticles. Pharm. Res. 6:413-417.
10. Borchard, G. 2001. Chitosan for gene delivery. Adv. Drug Del. Rev. 52:145-150.
11. Calvo, P., Remunan, C., Jato, J. L. V., and Alonso, M. J. 1997. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63:125-132.
12. Calvo, P., Bougaba, A., Appel, M., Fattel, E., Alonso, M. J., and Couvreur, P. 1998. Oligonucleotide-chitosan nanoparticles as new gene therapy vector. Proceedings of 2nd world Meeting APGI/APV. Paris: International Association for Pharmaceutical Technology.
13. Carreno, B. G., and Duncan, R. 1997. Evaluation of biological properties of soluble chitosan and chitosan microspheres. Intl. J. Pharm. 148:231-240.
14. Chandy, T., and Sharma, C. P. 1992. Chitosan beads and granules for oral sustained delivery of nifedipine: in vitro studies. Biomaterials 13:949-952.
15. Chandy, T., and Sharma, C. P. 1993. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials 14:939-944.
16. Chandy, T., and Sharma, C. P., Sunny, M. C. 1987. Inhibition of platelet adhesion to glow discharge modified surfaces. J. Biomat. Appln. 1:533-552.
17. Colo, G. D., Zambito, Y., Burgalassi, S., Serafini, A., and Saettone, M. F. 2002. Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Intl. J. Pharm. 248:115-122.
18. Dunn, E. J., Zang, X., Sun, D., and Goosen, M. F. A. 1993. Synthesis of N-(aminoalkyl) chitosan for microcapsules. J.Appl. Polym. Sci. 50:353-365.
19. Faldt, P., Bergenstahl, B., and Claesson, P. M. 1993. Stabilization by chitosan of soybean oil emultion coated with phospholipids and glycocholic acid. Coll. Surf. 71:187-195.
20. Fernandez, R. U., Calvo, P., Jato, J. R. V., and Alonso, M. J. 1999. Enhancement of nasal absorption of insulin using chitosan nanopartilces. Pharm. Res. 16:1576-1581.
21. Fernandez, R. U., Romani, D., Calvo, P., Jato, J. R. V., and Alonso, M. J. 1999a. Development of a freeze-dried formulation of insulin loaded chitosan nanoparticles intended for nasal administration. STP Pharm. Sci. 9:429-436.
22. Florea, B. I., Thanou, M., Geldof, M., Meaney, C., Junginger, H. E., and Borchard, G. 2000. Modified chitosan oligosaccharides as transfection agents for gene therapy of cystic fibrosis. In Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials. Paris: Controlled Release Society.
23. Gariepy, E. R., Leclair, G., Hildgen, P., Gupta, A., and Loroux, J. C. 2002. Thermosensitive chitosan based hydrogel containing liposomes for the delivery of hydrophilic molecules. J. Control. Rel. 82:373-383.
24. Genta, I., Costantini, M., Asti, A., Conti, B., and Montanari, L. 2000. Influence of glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres, Carbohydrate Polym. 36:81-88.
25. Genta, I., Perugini, P., Modena, T., Pavanetto, F., Castelli, F., Muzzarelli, R. A. A., Muzzarelli, C., and Conti, B. 2003. Miconazole-loaded 6-oxychitin-chitosan microcapsules. Carbohydrate Polym. 52:11-18.
26. Gupta, K. C., and Ravikumar, M. N. V. 1999. Structural changes and release characteristics of cross-linked chitosan beads in response to solution pH. J. M.S. Pure and Appl.Chem. A36:827-841.
27. Gupta, K. C., and Ravikumar, M. N. V. 2000. Drug release behavior of beads and microgranules of chitosan. Biomaterials 21:1115-1119.
28. Gupta, K. C., and Ravikumar, M. N. V. 2000a. Preparation, characterization and release profiles of pH-sensitive chitosan beads. Polym. Intl. 49:141-146.
29. Gupta, K. C., and Ravikumar, M. N. V. 2000b. Semi-interpenetrating polymer network beads of cross-linked chitosan-glycine for controlled release of chlorphenramine maleate. J. Appl. Polym. Sci. 76:672-683.
30. Hayashi, T., and Ikada. Y. 1991. Protease immobilization onto porous chitosan beads. J. Appl. Polym. Sci. 42:85-92.
31. Hejazi, R., and Amiji, M. 2003. Chitosan-based gastrointestinal delivery systems. J. Control. Rel. 89:151-165.
32. Henriksen, I., Smistad, G., and Karlsen, J. 1994. Interactions between liposomes and chitosan. Intl. J. Pharm. 101:227-236.
33. Hirano, H., Seino, H., Akiyama, I., and Nonaka, I. 1990. A biocompatible material for oral and intravenous administration. In Chitosan, ed, C. G. Gebelein and R. L. Dunn, 283-289. New York: Plenum Press.
34. Hirano, S., Seino, H., Akiyama, I., and Nonaka, I. 1989. Biocompatibility of chitosan by oral and intravenous administration. Polym. Eng. Sci. 59:897-901.
35. 10 alkyl glycosides branches: A temperature induced gelling polysaccharide. Macromolecules 24:3828-3833.
36. Hornof, M. D., Kast, C. E., and Schnurch, A. B. 2003. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Euro. J. Pharm. and Biopharm. 55:185-190.
37. Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., and Yang, C. 2002. Synthesis and characterization of chitosan-poly (acrylic acid) nanoparticles. Biomaterials 23:3193-3201.
38. Hughes, R. C. 1975. The complex carbohydrates of mammalian cell surfaces and their biological roles. Essays Biochem. 11:1-36.
39. Huguet, M. L., and Dellacherie, E. 1996. Calcium alginate beads coated with chitosan, effect of structure encapsulated materials on their release. Process Biochem. 31:745-751.
40. Huguet, M. L., Groboillot, A., Neufeld, R. J., Poncelet, D., and Dellacherie, E. 1994. Hemoglobin encapsulation in chitosan/calcium alginate beads. J. Appl. Polym. Sci. 51:1427-1432.
41. Huguet, M. L., Neufeld, R. J., and Dellacherie, E. 1996a. Calcium alginate beads coated with polycationic polymers: comparison of chitosan and DEAE-dextran. Process Biochem. 31:347-353.
42. Ida, G., Monica, C., Annalia, A., Bice, C., and Luisa, M. 1998. Influence of glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres. Carbohydrate Polym. 36:81-88.
43. Ilium, L. 1998. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15:1326-1331.
44. Ilium, L., Farraj, N. F., and Davis, S. S. 1994. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11:1186-1189.
45. Janes, K. A., Calvo, P., and Alonso, M. J. 2001. Polysaccharide colloidal partilce as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 47:83-97.
46. Janes, K. A., Fresneau, M. P., Marazuela, A., Fabra, A., and Alonso, M. J. 2001a. Chitosan nanoparticles as delivery systems for doxorubicin. J. Control. Rel. 73:255-267.
47. Kadiyala, I., Roy, K., Rice, J., and Leong, K. W. 2000. Transport kinetics of DNA nanopartilces in a Caco-2-peyer's patch model of intestinal epithelium. In Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials. Paris: Controlled Release Society.
48. Kast, C. E., and Schnurch, A. B. 2001. Thiolated polymers-thiomers, development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345-2352.
49. Kato, Y., Onishi, H., and Machida, M. 2000. A novel water-soluble N-succinyl chitosan-mitomycin C conjugate prepared by direct carbodiimide coupling: physicochemical properties, antitumor characteristics and systemic retention. STP Pharm. Sci. 10:133-142.
50. Kernels, S., Bogdanova, A., Kraehenbuhl, J. P., and Pringault, E. 1997. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science 277:949-952.
51. Knapczyk, J., Kroweczynski, L., Krzck, J., Brzeski, M., Nirnberg, E., Schenk, D., and Struszcyk, H. 1989. Chitin and chitosan: source, chemistry, biochemistry, physical properties and applications. In Requirements of Chitosan for Pharmaceutical and Biomedical Applications, ed. G. Shak, T. Anthonsen, and P. Sandford, 657-663. London: Elsevier.
52. Koga, D. 1998. Chitin enzymology-chitinase. Adv. Chitin Sci. 3:16-23.
53. Kokufuta, E., Zhang, Y. Q., and Tanaka, T. 1991. Saccharide sensitive phase transition of a lectin-loaded gel. Nature 351:302-304.
54. Kopecek, J., Vacik, J., and Lim, D. 1971. Permeability of membranes containing ionogenic group. J. Polym. Sci. 9:2801-2815.
55. Kurisawa, M., Matsuo, Y., and Yui, N. 1998. Modulated degradation of hydrogels with thermo-responsive network in relation to their swelling behavior. Macromol Chem. Phys. 199:705-709.
56. Lee, K. Y., Kwon, I. C., Kim, Y. H., Jo, W. H., and Jeong, S. Y. 1998. Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Rel. 51:213-220.
57. Lee, K. Y., Park, W. H., and Ha, W. S. 1997. Polyelectrolyte complexes of sodium alginate with chitosan or its derivatives. J. Appl. Polym. Sci. 63:425-432.
58. Lee, Y. M., and Shin, E. M. 1991. Pervaporation separation of water-ethanol through modified chitosan membranes, IV. Phosphorylated chitosan membranes. J. Membrane Sci. 64:145-152.
59. Lehr, C. M., Bowstra, J. A., Schacht, E. H., and Jungiger, H. E. 1992. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Intl. J. Pharm. 78:43-48.
60. Leong, K. W., Mao, H. Q., Truong, V. L., Roy, K., Walsh, S. M., and August, J. T. 1998. DNA-polycation nanospheres as non-viral gene delivery vehicles. J. Control. Rel. 53:183-193.
61. Lorenzo, M. L., Remunan, C. L., Jato, J. L. V., and Alonso, M. J. 1998. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Rel. 52:109-118.
62. Lubben, I. M. V. D., Verhoef, J. C., Borchard, G., and Junginger, H. E. 2001. Chitosan and its derivatives in mucosal drug and vaccine delivery. Euro. J. Pharm. Sci. 14:201-207.
63. Lueben, H. L., Leeuw, B. J. D., Langemeyer, B. W., Boer, A. G. D., Verhoef, J. C., and Junginger, H. E. 1996. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide buserelin in vivo. Pharm. Res. 13:1668-1672.
64. Mao, H. Q., Roy, K., Truong, V. L., August, J. T., and Leong, K. W. 1997. DNA-chitosan nanospheres, derivitization and storage stability. In Proceedings of 24th International Symposium on Controlled Release of Bioactive Materials. Stockholm: Controlled Release Society.
65. Mao, H. Q., Roy, K., Walsh, S. M., August, J. T., and Leong, K. W. 1996. DNA-chitosan nanoparticles for gene delivery. In Proceedings of 23rd International Symposium on Controlled Release of Bioactive Materials. Kyoto: Controlled Release Society.
66. Martin, L., Wilson, C. G., Koosha, F., Tetley, L., Gray, A. I., Senel, S., and Uchegbu, I. F. 2002. The release of model macromolecules controlled by the hydrophobicity of palmitoyl glycol chitosan hydrogels. J. Control. Rel. 80:87-91.
67. Mi, F. L., Shyu, S. S., Chen, C. T., and Schoung, J. Y. 1999. Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine: preparation of antigen-adsorbed microsphere and in vitro release. Biomaterials 20:1603-1612.
68. Mi, F. L., Sung, H. W., and Shyu, S. S. 2000. Synthesis and characterization of a novel chitosan based network prepared using naturally occuring crosslinker. J. Polym. Sci. Part A: Polym. Chem. 38:2804-2814.
69. Mi, F. L., Tan, Y. C., Liang, H. F., and Sung, H. W. 2002. In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. Biomaterials 23:181-191.
70. Miwa, A., Ishibe, A., Nakano, M., Yamahira, T., Itai, S., Jinno, S., and Kawahara, H. 1998. Development of novel chitosan derivatives as micellar carriers of taxol. Pharm. Res. 15:1844-1850.
71. Mumper, R. J., Wang, J., Claspell, J. M., and Rolland, A. P. 1995. Novel polymeric condensing carriers for gene delivery. In Proceedings of 22nd International Symposium on Controlled Release of Bioactive Materials. Washington: Controlled Release Society.
72. Murata, J., Ohya, Y., and Ouchi, T. 1997. Design of quaternary chitosan conjugate having antennary galactose residues as a gene delivery tool. Carbohydrate Polymers 32:105-109.
73. Muzzarelli, R. 1973. Natural chelating polymers. In Chitosan, ed. R. Muzzarelli, 144-176. Oxford: Pergamon Press.
74. Muzzarelli, R. A. A. 1997. Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell Mol. Life Sci. 53:131-140.
75. Nishimura, K., Nishimura, S., Seo, H., Nishi, N., Tokura, S., and Azuma, I. 1986. Macrophage activation with multiporous beads prepared from partially deacetylated chitin. J. Biomed. Mater. Res. 20:1359-1372.
76. Nishimura, S., Miyura, Y., Ren, L., Sato, M., Yamagishi, A., Nishi, N., Tokura, S., Kurita, K., and Ishii, S. 1993. An efficient method for the synthesis of novel amphiphilic polysaccharide by region and thermo selective modifications of chitosan. Chemistry letters 1623-1626.
77. Ohya, Y., Shiratani, M., Kobayashi, H., and Ouchi, T. 1994. Release behavior of 5-fluorouracil from chitosan-gel nanospheres immobilizing 5-fluorouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl. Chem. A31:629-642.
78. Okoli, G., Hortelano, G., and Leong, K. W. 2000. Oral delivery of plasmid DNA encoding the factor IX gene. In Proceedings of 27th International Symposium on Controlled Release of Bioactive Materials. Paris: Controlled Release Society.
79. Olson, R., Schwartzmiller, D., Weppner, W., and Winandy, R. 1988. Chitin and chitosan sources, chemistry, biochemistry, physical properties and applications. In Biomedical Application of Chitin and its Derivatives, ed. G. S. Braek, T. Antonsen, and P. Sandford, 813-828. London: Elsevier.
80. Onishi, H., Nagai, T., and Machida, Y. 1997. Applications of chitin and chitosan. In Application of Chitin, Chitosan, and their Derivatives to Drug Carriers for Microparticulated or Conjugated Drug Delivery System, ed. M. F. A. Goosen, 205-231. Lancaster: Technomic Publishing Co.
81. Onishi, H., Takahashi, H., Yoshiyasu, M., Machida, Y., and Nagai, T. 1994. Macromolecular prodrugs of cytarabine and mitomycin C with chitosan, N-succinyl chitosan and 6-O-carboxymethyl-chitin as drug carriers. In Chitin World, ed. L. S. Karnicki, M. M. Brzeski, P. J. Bykowski, and A. P. Wojtasz, 301-310. Wirtchaftsverlag NW: Bremerhaven.
82. Onishi, H., Takahashi, T., Yoshiyasu, M., and Machida, Y. 2001. Preparation and in vitro properties of N-succinyl chitosan or carboxyl methyl chitin-mitomycin C conjugates microparticles with specified size. Drug. Dev. Ind. Pharm. 27:659-667.
83. Park, Y. K., Park, Y. H., Shin, B. A., Choi, E. S., Park, Y. R., Akaike, T., and Cho, C. S. 2000. Galactosylated chitosan-graft-dextran as hepatocyte targeting DNA carrier. J. Control. Rel. 69:97-108.
84. Peppas, N. A. 1997. Hydrogels and drug delivery. Curr. Opin. Coll. Inter. Sci. 2:531-537.
85. Ramos, V. M., Rodriguez, N. M., Rodriguez, M. S., Heras, A., and Agullo, E. 2003. Modified chitosan carrying phosphonic and alkyl groups. Carbohydrate Polymers. 51:425-429.
86. Ravikumar, M. N. V., and Kumar, N. 2001. Polymeric controlled drug delivery systems: perspective issues and opportunities. Drug Devel. Ind. Pharm. 27:1-18.
87. Roldo, M., Hornof, M., Caliceti, P., and Schnurch, A. B. 2004. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Euro. J. Pharm. Biopharm. 57:115-121.
88. Roy, K., Mao, H. Q., Huang, S. K., and Leong, K. W. 1999. Oral gene delivery with chitosan-DNA nanopartilces generates immunologic protection in a murine model of peanut allergy. Nature Med. 5:387-391.
89. Roy, K., Mao, H. Q., and Leong, K. W. 1997. DNA-chitosan nanospheres, transfection efficiency and cellular uptake. In Proceedings of 24th International Symposium on Controlled Rellease of Bioactive Materials. Stockholm: Controlled Release Society.
90. Sato, M., Onishi, H., Machida, M., and Nagai, T. 1996. Preparation and drug release characteristics of the conjugates of mitomycin C with glycol-chitosan and n-succinyl chitosan. Biol. Pharm. Bull. 19:241-245.
91. Sato, M., Onishi, H., Takahara, J., Machida, Y., and Nagai, T. 1996a. In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan. Biol. Pharm. Bull. 19:1170-1177.
92. Sato, T., Shirakawa, N., Nishi, H., and Okahata, Y. 1996b. Formation of a DNA/polygalactosamine complex and its interaction with cells. Chem. Lett. 9:725-726.
93. Schipper, N. G. M., Hoogstraate, J. A., Boer, A. G. D., Varum, K. M., and Artursson, P. 1997. Chitosan as absorption enhancers for poorly absorbable drugs. 2. Mechanism of absorption enhancement. Pharm. Res. 14:923-929.
94. Schnurch, A. B., Guggi, D., and Pinter, Y. 2004. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Control. Rel. 94:177-186.
95. Schnurch, A. B., Hornof, M., and Zoidl, T. 2003. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Intl. J. Pharm. 260:229-237.
96. Shantha, K. L., and Harding, D. R. K. 2000. Preparation and in vitro evaluation of poly(N-vinyl-2-pyrrolidone-polyethylene glycol diacrylate)-chitosan interpolymeric pH-responsive hydrogels for oral drug delivery. Intl. J. Pharm. 207:65-70.
97. Sheehan, J. C., and Hlavka, J. J. 1956. The use of water-soluble and basic carbodiimides in peptide synthesis. J. Org. Chem. 21:439-441.
98. Shirahata, K. 1984. Mitomycin basic studies. In Derivatives and Activities, ed. T. Taguchi, 25-43. Tokyo: Kyowa Kikaku Tsushin.
99. Shu, X. Z., and Zhu, K. J. 2002. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release, Euro. J. Pharm. Biopharm. 54:235-243.
100. Sinha, V. R., Singla, A. K., Wadhawan, S., Kaushik, R., Kumria, R., Bansal, K., and Dhawan, S. 2004. Chitosan microspheres as a potential carrier for drugs. Intl. J. Pharm. 274:1-33.
101. Song, Y., Onishi, H., and Machida, Y. 1992. Synthesis and drug release characteristics of the conjugates of mitomycin C with N-succinyl-chitosan and carboxymethy-chitin. Chem. Pharm. Bull. 40:2822-2825.
102. Song, Y., Onishi, H., Machida, Y., and Nagai, T. 1995. Particle characteristics of carboxymethyl chitin-mitomycin C conjugate and their distribution and histological effect on some tissues after intravenous administration. STP Pharm. Sci. 5:162-170.
103. Song, Y., Onishi, H., Machida, Y., and Nagai, T. 1996. Drug release and antitumor characteristics of N-succinyl chitosan-mitomycin C as an implant. J. Control. Rel. 42:93-100.
104. Surini, S., Akiyama, H., Morishita, M., Nagai, T., and Takayama, K. 2003. Release phenomena of insulin from an implantable device composed of a polyion complex of chitosan and sodium hyaluronate. J. Control. Rel. 90:291-301.
105. Suzuki, A., and Tanaka, T. 1990. Phase transition in polymer gels induced by visible light. Nature 346:345-347.
106. Tien, C. L., Lacroix, M., Szabo, P. I., and Mateescu, M. A. 2003. N-acylated chitosan: hydrophobic matrices for controlled drug release. J.Control. Rel. 93:1-13.
107. Tobio, M., Gref, R., Sanchez, A., Langer, R., and Alonsa, M. J. 1998. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15:270-275.
108. Tobio, M., Sanchez, A., Vila, A., Soriano, I., Evora, C., and Jato, J. L. V. 2000. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles. Coll. Surf. Biointerf. 18:315-323.
109. Torrado, S., Prada, P., Torre, P. M., and Torrado, S. 2004. Chitosan-poly(acrylic)acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 25:917-923.
110. Tozaki, H., Fujita, T., Odoriba, T., Terabe, A., Suzuki, T., Tanaka, C., Okabe, S., and Muranishi, S. 1999. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using using chitosan capsules, therapeutic effects against 2,4,6-trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. Life Sci. 64:1155-1162.
111. Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., and Muranishi, S. 1997. Chitosan capsules for colon-specific drug delivery, improvement of insulin absorption from the rat colon. J. Pharm. Sci. 86:1016-1021.
112. Uchegbu, I. F., Sadiq, L., Arastoo, M., Gray, A. I., Wang, W., Waigh, R. D., and Schatzleina, A. G. 2001. Quaternary ammonium palmitoyl glycol chitosan - a new polysoap for drug delivery. Intl. J. Pharm. 224:185-189.
113. Urrusuno, R. F., Calvo, P., Lopez, C. R., Jato, J. L. V., and Alonso, M. J. 1999. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16:1576-1581.
114. Vila, A., Sanchez, A., Tobio, M., Calvo, P., and Alonso, M. J. 2002. Design of biodegradable particles for protein delivery. J. Control. Rel. 78:15-24.
115. Watzke, H. J., and Dieschbourg, C. 1994. Novel silica-biopolymer nanocomposites: the silica sol-gel process in biopolymer organogels. Adv. Coll. Interfac. Sci. 50:1-14.
116. Weiner, M. L. 1992. An overview of the regulatory status and of the safety of chitin and chitosan as food and pharmaceutical ingredients. In Advances in Chitin and Chitosan, ed. C. J. Brine, P. A. Sanford, and J. P. Zikakis, 670-678. London: Elsevier.
117. Williams, R. O., Barron, M. K., Alonso, M. J., and Remunan, C. L. 1998. Investigation of a Pmdi system containing chitosan microspheres and p134a. Intl. Pharm. 174:209-222.
118. Win, P. P., Ya, Y. S., Hong, K. J., and Kajiuchi, T. 2003. Formulation and characterization of pH sensitive drug carrier based on phosphorylated chitosan. Carbohydrate Polym. 53:305-310.
119. Yamaguchi, R., Arai, Y., Itoh, T., and Hirano, S. 1981. Preparation of partially N-succinylated chitosans and their cross-linked gels. Carbo. Res. 15:172-175.
120. Yamamoto, A., Tozaki, H., Okada, N., and Fujita, T. 2000. Colon-specific delivery of peptide drugs and anti-inflammatory drugs using chitosan capsules. STP Pharm. Sci. 10:23-34.
121. Yao, K., Peng, T., Xu, M., and Yuan, C. 1994. pH-dependent hydrolysis and drug release of chitosan/polyether interpenetrating polymer network hydrogel. Polym. Intl. 34:213-219.
122. Yao, K. D., Peng, T., Yu, J. J., Xu, M. X., and Goosen, M. F. A. 1995. Microcapsules/Microspheres related to chitosan. Rev. Macromol. Chem. Phys. C35:155-180.
123. Yin, Y., Xu, M., Chen, X., and Yao, K. D. 1996. Drug release behavior of chitosan/gelatine network polymer microspheres. Chinese Sci. Bull. 41: 1266-1270.
124. Yoshioka, H., Nonaka, K., Fukada, K., and Kazama, S. 1995. Chitosan derived polymer surfactants and their micellar properties. Biosci. Biotech. Biochem. 59:1901-1904.
125. Zenke, M., Steinlein, P., Wagner, E., Cotton, M., Beug, H., and Birnstiel, M. L. 1990. Receptor-mediated endocytosis of transferring-poly cation conjugates, an efficient to introduce DNA into hematopoietic cells. In Proceedings of the 87th National Academy of Sciences. Washington: National Academy of Sciences.